AGP Executive Report
Last update: 8 hours agoDementia Research: A £20 million UK hub will build a network of brain-health clinics using AI to improve prevention and diagnosis, with a goal of halving waits. Separately, University of Sheffield researchers identified early-forming amyloid particles that could offer new targets before Alzheimer’s damage becomes extensive. AI for Science: MIT researchers say their WorldParticle model can simulate materials ranging from shifting sand to changing proteins, potentially speeding up physical simulations. Drug Safety: The US FDA is adding a warning about rare vision loss to GLP-1 drug labels; its analysis found about six cases per 100,000 patients taking the drugs for at least a year. Climate: Scientists warn 2026 is likely to be the hottest year on record as COP31 begins, while ocean experts urge stronger action to protect marine ecosystems. Genetics: A new two-toed sloth genome points to extra copies of energy-related genes as a possible clue to how the animals live on remarkably little energy. Vaccines: Valneva reports that 94% of adults in its study retained an antibody response five years after a single chikungunya vaccine dose.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
